Login / Signup

An investigation of the differential therapeutic effects of romosozumab on postmenopausal osteoporosis patients with or without rheumatoid arthritis complications: a case-control study.

Kosuke EbinaYoshio NagayamaMasafumi KashiiHideki TsuboiGensuke OkamuraAkira MiyamaYuki EtaniTakaaki NoguchiMakoto HiraoTaihei MiuraYuji FukudaTakuya KuriharaKen NakataSeiji Okada
Published in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2024)
The efficacy of ROMO may be attenuated by RA-related factors.
Keyphrases
  • rheumatoid arthritis
  • bone mineral density
  • disease activity
  • postmenopausal women
  • ankylosing spondylitis
  • interstitial lung disease
  • body composition
  • risk factors
  • systemic lupus erythematosus
  • systemic sclerosis